Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Bone and Calcium Disorders
•
Male and Female Reproductive Disorders
•
General Endocrinology
How do you view the efficacy of estrogen replacement therapy in trans-women with regards to osteoporosis prevention and treatment?
Related Questions
Do oral contraceptives lower bone mineral density in women with hypothalamic amenorrhea by lowering IGF-1?
Is bilateral oophorectomy the first-line treatment for ovarian hyperthecosis?
When do you recommend the use of oral testosterone replacement over injectable testosterone?
Does a patient with an endometrial ablation need progesterone if prescribed estradiol for menopausal HRT?
How would you approach a finding of osteoporosis (Z score -4.5) in a recently postpartum patient who had DEXA sent for long-term low-dose glucocorticoid use?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Can romosozumab be used for patients who develop osteoporosis secondary to mild autonomous cortisol excess?
Do you recommend the use of GLP 1 R agonist therapy for obese women with PCOS who are actively trying to conceive?
Do you regularly counsel younger women of childbearing age about the impact of Tirzepatide on oral hormonal contraception?
Would you add cholecalciferol or ergocalciferol to calcitriol therapy in patients with post operative hypoparathyroidism who have low 25 OH vitamin D levels?
